Work

Areas of Consensus and Differences Among a Panel of Experts on the Optimal Use of Newly Approved Agents to Treat Multiple Myeloma (MM): Results from an Annually Updated Online Decision Support Tool

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.2379.2379

Authors: Timothy A Quill, Kristen M Rosenthal, Shaji Kumar, Suzanne Lentzsch, Sagar Lonial, G. David Roodman, Kevin L Obholz, Kenneth C. Anderson

Institutions: Mayo Clinic, Columbia University Irving Medical Center, Emory University, Winship Cancer Institute, Indiana University Indianapolis, Indiana University School of Medicine, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602445427

FWCI:

Cites:

Cited by:

Related to: 10